Operating Structure | i2.JP (Innovation Infusion Japan) | Astrazeneca

AstraZeneca operates a Healthcare Open Innovation Network with various organizations and companies in the healthcare industry around the world, with the common goal of achieving patient-centered healthcare.

In Japan, the network was launched in November 2020 as i2.JP. i2.JP is now the largest ecosystem in Japan that connects domestic startups, medical professionals, local governments, academia, and private companies to work together to solve problems in the healthcare field and create practical and optimal solutions through collective knowledge. i2.JP, including the management of this website, is operated by AstraZeneca K.K.

For inquiries about i2.JP, please contact here.

About AstraZeneca:

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on social media @AstraZeneca.